BaroFold Grants Protein Technology Research License to Pfizer.BOULDER, Colo. -- BaroFold, Inc. announced today the granting of a multi-site research license to Pfizer, Inc. (NYSE NYSE See: New York Stock Exchange : PFE 1. (text, editor) PFE - Programmer's File Editor. 2. (language) PFE - Portable Forth Environment. ) for BaroFold's proprietary PreEMT[TM] high pressure technology for solubilizing, disaggregating and refolding proteins. Financial terms were not disclosed. Pfizer joins several other biotechnology firms and pharmaceutical corporations who have licensed BaroFold's technology to refold Re`fold´ v. t. 1. To fold again. and produce proteins. "We are pleased to be working with Pfizer, a global leader in discovering and developing breakthrough medicines," said Lyndal Hesterberg, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of BaroFold Inc. "The use of the BaroFold technology has broken a log-jam for many companies in target discovery for developing clean three-dimensional protein structures for crystallography and rational drug design. PreEMT technology has been validated by various partners through use in over two hundred proteins. We hope to support future development of important therapeutic programs at Pfizer." About BaroFold BaroFold is a fully integrated bio-therapeutics company. The Company's PreEMT hydrostatic pressure hydrostatic pressure The pressure exerted by a fluid at equilibrium at a given point within the fluid, due to the force of gravity. Hydrostatic pressure increases in proportion to depth measured from the surface because of the increasing weight of fluid technology enables improved, safer, proprietary protein therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. , providing life-cycle extensions and creating new protein therapeutics through the use of a patented protein refolding technology. The Company also leverages its technology through partnerships with research facilities, major biotechnology and pharmaceutical companies. For additional information about the company, please visit http://www.barofold.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion